How can I fund a study?
Contact CMSRI at mail@CMSRI.org and ask about prioritized research projects or the option of helping design a study in your area of interest.
How can I help?
Partner with CMSRI. Donate to us and join the effort to halt the epidemic of chronic illness. Learn about how toxins in everyday items and food affect one’s health and read about adverse reactions to vaccines and medicines. Learn about how medical and scientific research is conducted and think critically and independently about the health choices you make for yourself and your family. Share your thoughts with us online – via email at mail@CMSRI.org.
Who should not be vaccinated?
In an article published in the Pharmacological Review entitled "Predicting post-vaccination autoimmunity: Who might be at risk?" Dr. Yehuda Shoenfeld, editor of "Vaccines and Autoimmunity," identified four groups of individuals who might be susceptible to developing vaccine-induced autoimmune/inflammatory syndrome induced by adjuvants (ASIA).
What is the Chronic Illness and Disability Epidemic?
The last three decades saw rates soar for asthma, allergies, autism, seizure disorders, eczema, autoimmune disorders, cancer, diabetes and Alzheimer’s disease. Those who cope with these diseases (many of which have no cure) often take daily medications and undergo therapies to manage symptoms. Ultimately, many people face disability, harming their ability to function and enjoy life.
Who develops chronic illness?
Children and older adults are primarily affected by chronic illness and disability. Children are now being diagnosed and treated for chronic health conditions at a rate equal to or greater than those over the age of fifty. Age- related neurological disease affecting cognitive and motor function is expected to affect one out of every two people over the age of 60 in the next three decades.
Can chronic illness be prevented?
Some people are at greater risk than others. Risk factors can include one’s genetic background, geographical location, cumulative toxic exposures, prior illness, fetal and maternal exposures, diet, occupation, amount of vaccines and prescription medicines, silicone implants, and other unidentified factors. Studying significant risk factors in a scientific, quantifiable way can result in policies that address these factors and help reduce the amount of chronic illness and disability in the US.
What are the goals of CMSRI?
The research’s conclusions will provide information to policymakers, health experts and the public to better understand what is driving childhood chronic illness, disability and age-related neurological disorders. These illnesses not only cost the patients a great deal, but are debilitating and even life threatening. Our goal is to improve public health, reduce health care costs and restore quality of life for those who suffer. CMSRI sees chronic illness among children as a national crisis – one that affects academic performance and ultimately, our economic competitiveness in the world.
How will CMSRI make a difference?
CMSRI is focused on finding the causes of chronic disease and disability through funding collaborative research on the subject. With its experienced scientific advisory board, CMSRI can identify strategic research projects aimed at discovering causal factors. All CMSRI funded research is intended to be peer reviewed and published in highly regarded, mainstream journals. CMSRI research will be independent and rigorous.
Why is CMSRI focusing on vaccine safety?
Vaccines are among the earliest and most frequent medical interventions in an individual’s life. A baby is exposed to vaccines in the womb via the mother during pregnancy, as early as 12 hours after birth and throughout early childhood. Vaccine exposure is nearly universal in the US as over 95% of families vaccinate their children according to the CDC recommended schedule. Administering vaccines is the most widespread medical intervention across the population.
Why is vaccine safety a concern?
Vaccines are administered to healthy people to keep them from developing an infectious disease and therefore should involve the smallest health risks possible. Vaccination policies have evolved over the past 80 years. In recent decades, public health authorities have increasingly relied on vaccination as a tool to prevent infectious disease, with the number of vaccines and doses tripling since the 1980’s. During the same period of infectious disease decline, chronic disease and disability have skyrocketed. To date, no rigorous study has measured the biological and genetic changes as a result of vaccination. Animal model studies of vaccine ingredients and preparations have demonstrated cause for concern. Animals studied include mice, rats, sheep, primates, horses and dogs.
Why are children and elderly more affected by chronic illness?
Very young and older populations have specialized physiology which may contribute to higher rates of chronic health conditions. An infant’s immature blood brain barriers and immune system means that toxins have a proportionally greater effect. With the aged, often the kidneys and liver are less efficient, resulting in the build-up of more toxins in their systems.
Why are age-related neurological diseases relevant to children’s health?
Conditions such as Alzheimer’s and Parkinson’s disease have no known definitive cause. Although genetics play a role, these conditions are likely caused by gene-toxin interactions. Toxic exposures during childhood may set the stage for neurological disease later in life. During a lifetime, toxins can bioaccumulate at a greater rate than they can be excreted. Accumulation of toxins and toxic byproducts in the brain begins to increase as people age.
What are some of the specific concerns related to vaccine safety?
There are no studies on Vaccines in the combinations in which they appear on the CDC recommended schedule. A comparative health outcomes study has never been conducted to determine whether the vaccine program as a whole is resulting in overall improved health outcomes. Certain toxic ingredients in vaccines have not been individually tested for safety such as aluminum adjuvants, polysorbate 80 and Thimerosal. Also, no study exists that looks at the potential for contamination from the culture medium or possible long term effects of cell substrate contamination. Subjects should be followed for sufficient periods to capture long term events, such as autoimmune diseases, which can take years to develop. Finally, the use of aluminum placebos in vaccine studies hides the background levels of adverse reactions. Placebos should be inert in order to assess the safety of a vaccine.
Will CMSRI accept pharmaceutical industry funding?
No. All funding will be obtained through private individuals, foundations, and non-pharmaceutical industry sources. All potential conflicts of interest will be disclosed by the author(s).